DEVA Deva Holding A.S.

1.416USD71.40 TRY · BIST-1.24%Mkt Cap: 283.15M USDP/E: —

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective…

Key Statistics

Company
Market Cap283.15M USD
Enterprise Value360.78M USD
Revenue (TTM)407.58M USD
Gross Profit125.00M USD
Net Income (TTM)-16.00M USD
Revenue/Share2.04 USD
Last Price1.416 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees3.1K
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINTRADEVAW91E2
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA4.96
EV/Revenue0.89
P/S0.69
P/B0.42
EPS (TTM)-0.08 USD
EPS (Forward)—
52W Range
1.14027% of range2.167
52W High2.167 USD
52W Low1.140 USD
Profitability
Gross Margin32.76%
Oper. Margin9.98%
EBITDA Margin17.83%
Profit Margin-4.19%
ROE-3.07%
ROA-2.14%
ROIC0.03%
ROCE0.03%
Growth
Revenue Growth5.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF104.78M USD
CapEx (TTM)46.89M USD
FCF Margin-19.04%
FCF Yield-27.40%
Net Debt77.57M USD
Net Debt/EBITDA1.07
Net Debt/FCF—
Balance Sheet
Debt/Equity0.23
Current Ratio2.36
Quick Ratio1.28
Book Value/Sh3.35 USD
Cash/Share0.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield0.30%
Payout Ratio0.00%
Ex-Div DateJun 25, 2024
Pay Date—
Splits
Last Split1:1000
Split DateJan 3, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.200.02M
Float35.60M
Insiders82.20%
Institutions0.36%
Technical
SMA 501.664 (-14.9%)
SMA 2001.472 (-3.8%)
Beta0.10
S&P 52W Chg12.00%
Avg Vol (30d)333.89K
Avg Vol (10d)440.32K
Technical Indicators
RSI (14)37.7
MACD-2.0391
MACD Signal-2.2025
MACD Hist.+0.1634
BB Upper1.605 USD
BB Middle1.473 USD
BB Lower1.341 USD
BB Width17.98%
ATR (14)0.0674 USD
Vol Ratio (20d)0.36x

About Deva Holding A.S. (IST: DEVA)

›

Deva Holding A.S. (IST: DEVA) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 3,079 employees.

The shares were at 71.40 TRY on 19 November 2026, up 14.8% over 52 weeks. Its 52-week range is 57.50 TRY to 109.30 TRY: the price is 34.7% below the high and 24.2% above the low.

Its market capitalisation is 14.28B TRY.

Deva Holding A.S. reports return on equity of -3.1%, an operating margin of 10.0% and revenue up 5.7% year over year.

Its debt exceeds its cash by 3.91B TRY, a debt-to-equity ratio of 0.23. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.